127 related articles for article (PubMed ID: 25428277)
1. Enhanced bioavailability and safety of curcumagalactomannosides as a dietary ingredient.
Liju VB; Jeena K; Kumar D; Maliakel B; Kuttan R; I M K
Food Funct; 2015 Jan; 6(1):276-86. PubMed ID: 25428277
[TBL] [Abstract][Full Text] [Related]
2. Safety, Tolerance, and Enhanced Efficacy of a Bioavailable Formulation of Curcumin With Fenugreek Dietary Fiber on Occupational Stress: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Pandaran Sudheeran S; Jacob D; Natinga Mulakal J; Gopinathan Nair G; Maliakel A; Maliakel B; Kuttan R; Im K
J Clin Psychopharmacol; 2016 Jun; 36(3):236-43. PubMed ID: 27043120
[TBL] [Abstract][Full Text] [Related]
3. Brain regional pharmacokinetics following the oral administration of curcumagalactomannosides and its relation to cognitive function.
Kannan RG; Abhilash MB; Dinesh K; Syam DS; Balu M; Sibi I; Krishnakumar IM
Nutr Neurosci; 2022 Sep; 25(9):1928-1939. PubMed ID: 33877014
[TBL] [Abstract][Full Text] [Related]
4. A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis.
Banik K; Khatoon E; Hegde M; Thakur KK; Puppala ER; Naidu VGM; Kunnumakkara AB
Life Sci; 2021 Dec; 287():120074. PubMed ID: 34687757
[TBL] [Abstract][Full Text] [Related]
5. Review: bioavailability and efficacy of 'free' curcuminoids from curcumagalactomannoside (CGM) curcumin formulation.
Matthewman C; Krishnakumar IM; Swick AG
Nutr Res Rev; 2024 Jun; 37(1):14-31. PubMed ID: 36655498
[TBL] [Abstract][Full Text] [Related]
6. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects.
Purpura M; Lowery RP; Wilson JM; Mannan H; Münch G; Razmovski-Naumovski V
Eur J Nutr; 2018 Apr; 57(3):929-938. PubMed ID: 28204880
[TBL] [Abstract][Full Text] [Related]
7. Comparative neuroprotective effects of native curcumin and its galactomannoside formulation in carbofuran-induced neurotoxicity model.
E R S; P P B; Nair SS; Maliakel B; Kuttan R; I M K
Nat Prod Res; 2020 May; 34(10):1456-1460. PubMed ID: 30580600
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro).
Swaroop A; Bagchi M; Kumar P; Preuss HG; Tiwari K; Marone PA; Bagchi D
Toxicol Mech Methods; 2014 Oct; 24(7):495-503. PubMed ID: 25045923
[TBL] [Abstract][Full Text] [Related]
9. Curcumin-galactomannoside complex inhibits pathogenesis in Ox-LDL-challenged human peripheral blood mononuclear cells.
Saji S; Asha S; Svenia PJ; Ratheesh M; Sheethal S; Sandya S; Krishnakumar IM
Inflammopharmacology; 2018 Oct; 26(5):1273-1282. PubMed ID: 29633105
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of a Sustained Release Formulation of Curcumin.
Madhavi D; Kagan D
Integr Med (Encinitas); 2014 Jun; 13(3):24-30. PubMed ID: 26770097
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
Cui J; Yu B; Zhao Y; Zhu W; Li H; Lou H; Zhai G
Int J Pharm; 2009 Apr; 371(1-2):148-55. PubMed ID: 19124065
[TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of Whole Algalin Protein (WAP) from Chlorella protothecoides.
Szabo NJ; Matulka RA; Chan T
Food Chem Toxicol; 2013 Sep; 59():34-45. PubMed ID: 23733102
[TBL] [Abstract][Full Text] [Related]
14. Dietary safety of cycloastragenol from Astragalus spp.: subchronic toxicity and genotoxicity studies.
Szabo NJ
Food Chem Toxicol; 2014 Feb; 64():322-34. PubMed ID: 24316212
[TBL] [Abstract][Full Text] [Related]
15. Safety evaluation of zeaxanthin concentrate (OmniXan™): acute, subchronic toxicity and mutagenicity studies.
Ravi KB; Raghunatha Reddy KR; Shankaranarayanan J; Deshpande JV; Juturu V; Soni MG
Food Chem Toxicol; 2014 Oct; 72():30-9. PubMed ID: 24964014
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of Radiation-Induced Damages in Mice by Curcuminoids: The Role of Bioavailability.
Liju VB; Thomas A; Sivadasan SD; Kuttan R; Maliakel B; Im K
Nutr Cancer; 2021; 73(4):617-629. PubMed ID: 32449395
[TBL] [Abstract][Full Text] [Related]
17. Acute and 13 weeks subchronic toxicological evaluation of naringin in Sprague-Dawley rats.
Li P; Wang S; Guan X; Liu B; Wang Y; Xu K; Peng W; Su W; Zhang K
Food Chem Toxicol; 2013 Oct; 60():1-9. PubMed ID: 23871784
[TBL] [Abstract][Full Text] [Related]
18. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
19. Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC) method.
Marczylo TH; Steward WP; Gescher AJ
J Agric Food Chem; 2009 Feb; 57(3):797-803. PubMed ID: 19152267
[TBL] [Abstract][Full Text] [Related]
20. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
